Clinical Trial Update: Plasma Rich in Growth Factors for Treatment of Medication Related Osteonecrosis of the Jaw [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating plasma rich in growth factors for osteonecrosis of the jaw associated with medications; current status is unknown for Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteonecrosis Due to Drugs Jaw
• Osteonecrosis of the Jaw

Drugs mentioned

• Plasma Rich in Growth Factors (platelet-rich growth factor preparation)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Osteonecrosis Due to Drugs, Jaw | Phase 2, Phase 3 | Status: UNKNOWN